---
document_datetime: 2023-09-21 19:59:32
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/steps-after-cutoff/nonafact-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
document_name: nonafact-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
version: success
processing_time: 2.3516014
conversion_datetime: 2025-12-25 03:58:32.228491
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Procedural steps taken  after granting  the Marketing Authorisation

For procedures  finalised after I February  2004 please refer to module 88.

| Scope                                                                                                                                                                                                | Application number   | Type of modificationl   | Notilication/ Opinion issued on!   | Commission Decision Issued/amended on   |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------|-------------------------|------------------------------------|-----------------------------------------|
| Change in the name and/or address ofthe marketing authorisation holder                                                                                                                               | v0l                  |                         | 04.04.03                           | 12.05.03                                |
| Charree in test orocedures ofthe medicinal oroduct                                                                                                                                                   | v02                  |                         | 08.0s.01                           | 14.0s.03                                |
| Change in test procedure ofactive substance and Change in test procedrres ofthe rnedicinai prcduct and Change in test prccedure for starting material/intermediate used in nanuf. ofactive substance | u03                  |                         | 24.07.O1                           | 0s.08.03                                |
| Update ofor chanse(s) to the oharmaceutical dmrrmentarion                                                                                                                                            | II/05                |                         | 21.01.04                           | 26.41 04                                |

I In accordance with Commission  Regulation  @C)  No. 542195  of l0 March  1995, as amended:  I refers to a minor variation (T1pe  I variation);  II refers to a major variation (Tpe II variation);  UII refers to a minor variation  following the procedure  set out in Article  6,7 and8 of the Regulation; X refers to an Annex II application.

## for starting  material/intermediate used  in nanuf. ofactive  substance Update  ofor chanse(s) to the oharmaceutical  dmrrmentarion Medicinal product no longer authorised

T refers to a transfer  of a Marketing  Authorisation  in accordance with Commission Regulation (EC) No 2141196  of 7 November  1996.

N refers to a notification  in accordance with Article l0(3) of Council Directiveg2l2zIEEC  of 3l March 1992.

2 For Notifications and Type I variations, the date of entry  into force of the change is the EMEA Notification date. The Commission Decision will be amended accordingly.